KERRY WOOD: Open Payments
NPI 1033760772 · FOUNTAIN VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,802 in 92 payments from 19 companies in 2025. Trend: 2023 $1,534 · 2024 $2,101 · 2025 $1,802
Food & beverage: $1,802
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 4 | $238 |
| Novartis Pharmaceuticals Corporation | 11 | $237 |
| Alnylam Pharmaceuticals Inc. | 7 | $190 |
| Novo Nordisk Inc | 8 | $159 |
| Amgen Inc. | 7 | $150 |
| Merck Sharp & Dohme LLC | 6 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $100 |
| AtriCure, Inc. | 3 | $91 |
| E.R. Squibb & Sons, L.L.C. | 5 | $89 |
| SCPHARMACEUTICALS INC. | 4 | $89 |
Products named: LEQVIO, AMVUTTRA, REPATHA, Wegovy, JARDIANCE, MICRA, ATRICLIP LAA EXCLUSION SYSTEM, CAMZYOS.
Industry payments across CA — which companies pay providers there.
